Synopsys Enters into $1 Billion Accelerated Share Repurchase Agreement
SYNOPSYS INC
Subscribe to track SNPS
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Synopsys, Inc. (NASDAQ: SNPS) - Form 8-K Filing
Event: $1.0 Billion Accelerated Share Repurchase (ASR) Agreement Counterparty: JPMorgan Chase Bank, National Association Initial Delivery: ~1,735,000 shares Final Settlement Date: On or before January 5, 2027 Determination: Based on volume-weighted average price (VWAP) less a discount
Comprehensive Analysis
Event Overview
On October 5, 2026, Synopsys, Inc. filed a Form 8-K under Item 8.01 disclosing that it entered into an Accelerated Share Repurchase (ASR) agreement with JPMorgan Chase Bank, National Association to repurchase an aggregate of $1 billion of Synopsys common stock.
Key Agreement Terms
- Total Program Size: $1.0 billion aggregate commitment.
- Initial Share Delivery: Approximately 1,735,000 shares will be delivered initially to Synopsys.
- Pricing Mechanism: The ultimate number of shares repurchased will be determined by the average daily volume-weighted average price (VWAP) of Synopsys common stock over the term of the agreement, less an agreed-upon discount.
- Settlement Timeline: The remaining settlement, if any, is scheduled to conclude on or before January 5, 2027.
Strategic & Capital Allocation Context
- Share Count Reduction: The immediate delivery of approximately 1.735 million shares, followed by final settlement in early January 2027, will provide accretive benefits to earnings per share (EPS).
- Balance Sheet Strength: Entering an ASR of this scale highlights management's confidence in strong ongoing free cash flow generation and reinforces their commitment to returning capital to shareholders.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
